DiaSys Announces Renewal of 3-Year Sales Agreement in Turkey; Receives Additional Order For 50 Workstations and 50,000 Parasep(R) Tubes.Health/Medical Writers WATERBURY, Conn.--(BW HealthWire)--Jan. 24, 2002 DiaSys Corporation (AMEX AMEX See: American Stock Exchange :DYX DYX Dyslexia ) today announced that its European subsidiary, DiaSys Europe, Ltd., has entered into another 3-Year Sales and Service Agreement with Lenta Teshis Urunleri Ticaret ve Sanayi Ltd. Sti. (Lenta). Lenta, a leading distributor of laboratory diagnostic equipment, headquartered in Istanbul, has 14 correspondent offices throughout Turkey. Under the agreement Lenta will sell, and service, DiaSys workstations to the more than 5,000 medical facilities located throughout Turkey, Turkmenistan, Uzbekistan, Kazakhstan, and Kyrgyzstan. DiaSys further reported that Lenta has placed an additional order for 50 DiaSys Ova & Parasite Analysis Workstations and 50,000 Parasep tubes, valued at approximately $190,000. Thirty of the 50 workstations and 50,000 Parasep tubes were earmarked for immediate shipment to Lenta to meet their current customer demands. Parasep, DiaSys' proprietary line of filter-concentrator tubes, are used in routine laboratory testing procedures for ova and intestinal parasite Intestinal parasites are parasites that populate the gastro-intestinal tract. In humans, they are often spread by poor hygiene related to feces, contact with animals, or poorly cooked food containing parasites. analysis. DiaSys Corporation designs, develops, manufactures and internationally distributes medical laboratory instrumentation, consumables, reagents and test kits with applications in urinalysis, microbiology and cytology cytology (sītŏl`əjē), in biology, the study of the structure of all normal and abnormal components of cells and the changes, movements, and transformations of such components. . DiaSys and Parasep are registered trademarks of DiaSys Corporation. The foregoing press release includes "forward looking statements" within the meaning of, and made pursuant to, the safe harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Such forward looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance or achievements of the Company or events, or timing of events, relating to relating to relate prep → concernant relating to relate prep → bezüglich +gen, mit Bezug auf +acc the Company to materially differ from those expressed or implied by such forward looking statements. DiaSys refers interested parties to its most recent Annual Report on Form 10-KSB and other SEC filings for a complete description of, and discussions about, the Company. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion